Comparative efficacy and safety of six non-ergot dopamine-receptor agonists in early Parkinson's disease: a systematic review and network meta-analysis

BACKGROUND: Non-ergot dopamine agonists (NEDAs) have been used as monotherapy or as an adjunctive therapy to levodopa for many years. Novel long-acting formulations of NEDAs including pramipexole extended-release (ER), ropinirole prolonged-release (PR), and rotigotine transdermal patch have been dev...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xiang-Ting, Zhang, Qian, Chen, Fei-Fei, Wen, Si-Yuan, Zhou, Chang-Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10312085/
https://www.ncbi.nlm.nih.gov/pubmed/37396766
http://dx.doi.org/10.3389/fneur.2023.1183823

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10312085/
https://www.ncbi.nlm.nih.gov/pubmed/37396766
http://dx.doi.org/10.3389/fneur.2023.1183823

Ejemplares similares